These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 11116046

  • 1. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.
    Bajzar L.
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2511-8. PubMed ID: 11116046
    [Abstract] [Full Text] [Related]

  • 2. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Nesheim M, Morser J, Tracy PB.
    J Biol Chem; 1998 Jan 30; 273(5):2792-8. PubMed ID: 9446587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteolytic activation of purified human procarboxypeptidase U.
    Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF.
    Clin Chim Acta; 2000 Feb 25; 292(1-2):25-40. PubMed ID: 10686274
    [Abstract] [Full Text] [Related]

  • 5. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T.
    Nihon Yakurigaku Zasshi; 2000 Nov 25; 116(5):298-303. PubMed ID: 11215380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB, Wang W, Bajzar L, Nesheim ME.
    J Biol Chem; 1998 Jan 23; 273(4):2127-35. PubMed ID: 9442053
    [Abstract] [Full Text] [Related]

  • 9. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
    Bajzar L, Nesheim ME, Tracy PB.
    Blood; 1996 Sep 15; 88(6):2093-100. PubMed ID: 8822928
    [Abstract] [Full Text] [Related]

  • 10. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
    Kokame K, Zheng X, Sadler JE.
    J Biol Chem; 1998 May 15; 273(20):12135-9. PubMed ID: 9575159
    [Abstract] [Full Text] [Related]

  • 11. Thrombin and fibrinolysis.
    Nesheim M.
    Chest; 2003 Sep 15; 124(3 Suppl):33S-9S. PubMed ID: 12970122
    [Abstract] [Full Text] [Related]

  • 12. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO, Bouma BN.
    Arterioscler Thromb Vasc Biol; 2006 Nov 15; 26(11):2445-53. PubMed ID: 16960106
    [Abstract] [Full Text] [Related]

  • 13. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT, Boffa MB.
    J Thromb Haemost; 2016 Apr 15; 14(4):772-83. PubMed ID: 26816270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M, Nagashima M, Knappe S, Zhao L, Morser J, Nesheim M.
    J Biol Chem; 2002 Mar 22; 277(12):9944-51. PubMed ID: 11786552
    [Abstract] [Full Text] [Related]

  • 16. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
    Hall SW, Nagashima M, Zhao L, Morser J, Leung LL.
    J Biol Chem; 1999 Sep 03; 274(36):25510-6. PubMed ID: 10464282
    [Abstract] [Full Text] [Related]

  • 17. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
    Mochizuki L, Sano H, Honkura N, Masumoto K, Urano T, Suzuki Y.
    Thromb Haemost; 2023 Jan 03; 123(1):16-26. PubMed ID: 36307100
    [Abstract] [Full Text] [Related]

  • 18. Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.
    Schadinger SL, Lin JH, Garand M, Boffa MB.
    J Thromb Haemost; 2010 Nov 03; 8(11):2523-9. PubMed ID: 20723026
    [Abstract] [Full Text] [Related]

  • 19. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C, Stafford AR, Fredenburgh JC, Weitz JI, Gils A, Declerck PJ, Kim PY.
    Thromb Haemost; 2017 Jul 26; 117(8):1509-1517. PubMed ID: 28640323
    [Abstract] [Full Text] [Related]

  • 20. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
    Wang W, Nagashima M, Schneider M, Morser J, Nesheim M.
    J Biol Chem; 2000 Jul 28; 275(30):22942-7. PubMed ID: 10801821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.